Global Respiratory Monitoring Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type of Device;

Spirometers, Peak Flow Meters, Sleep Test Devices, Gas Analyzers, Pulse Oximeters, Capnographs, and Others.

By Application;

Chronic Obstructive Pulmonary Disease, Infectious Diseases, Asthma, and Others.

By End User;

Laboratories, Hospitals, and Home Use.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn143712568 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Respiratory Monitoring Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Respiratory Monitoring Devices Market was valued at USD 8,107.47 million. The size of this market is expected to increase to USD 14,148.91 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.3%.

The Global Respiratory Monitoring Devices Market is witnessing rapid growth driven by the increasing prevalence of respiratory diseases, technological advancements in monitoring technologies, and growing awareness about the importance of respiratory health. Respiratory monitoring devices play a crucial role in assessing lung function, detecting respiratory abnormalities, and guiding treatment decisions across a wide range of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections.

As respiratory diseases continue to pose significant health burdens worldwide, there is a growing emphasis on early disease detection, proactive management, and personalized treatment approaches. Respiratory monitoring devices enable healthcare providers to monitor respiratory parameters, such as lung function, oxygen saturation, respiratory rate, and airway resistance, facilitating timely interventions, optimizing treatment regimens, and improving patient outcomes.

Technological advancements have revolutionized the respiratory monitoring devices market, leading to the development of innovative devices with enhanced accuracy, portability, and connectivity features. Advanced spirometers, peak flow meters, pulse oximeters, capnographs, and sleep apnea monitoring devices offer non-invasive and user-friendly solutions for assessing respiratory function and monitoring disease progression in various clinical settings.

The increasing prevalence of respiratory diseases, attributed to factors such as aging populations, air pollution, smoking, and sedentary lifestyles, drives the demand for respiratory monitoring devices worldwide. According to the World Health Organization (WHO), respiratory diseases, including COPD, asthma, and respiratory infections, are among the leading causes of morbidity and mortality globally, highlighting the urgent need for effective monitoring and management strategies.

The market is characterized by intense competition, technological innovation, and strategic collaborations among key market players. Companies are investing in research and development initiatives to develop next-generation monitoring devices, expand their product portfolios, and enhance market competitiveness.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type of Device
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Respiratory Monitoring Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising respiratory disease prevalence
        2. Aging population
        3. Increased health awareness
        4. Early detection demand
        5. Remote monitoring adoption
      2. Restraints
        1. Stringent regulations
        2. Limited healthcare access
        3. Diagnostic accuracy challenges
        4. Data security risks
        5. Workforce shortages
      3. Opportunities
        1. Wearable tech adoption
        2. Telemedicine expansion
        3. Home-based healthcare
        4. Personalized medicine growth
        5. Digital health integration
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Respiratory Monitoring Devices Market, By Type of Device, 2021 - 2031 (USD Million)
      1. Spirometers
      2. Peak Flow Meters
      3. Sleep Test Devices
      4. Gas Analyzers
      5. Pulse Oximeters
      6. Capnographs
      7. Others
    2. Global Respiratory Monitoring Devices Market, By Application, 2021 - 2031 (USD Million)
      1. Chronic Obstructive Pulmonary Disease
      2. Infectious Diseases
      3. Asthma
      4. Others
    3. Global Respiratory Monitoring Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Laboratories
      2. Hospitals
      3. Home Use
    4. Global Respiratory Monitoring Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic (Ireland)
      2. General Electric (U.S.)
      3. Masimo (U.S.)
      4. Koninklijke Philips N.V. (U.S.)
      5. Welch Allyn, (U.S.)
      6. Smiths Medical (U.S.)
      7. MGC Diagnostics Corporation (U.S.)
      8. Novelda AS (Norway)
      9. Dragerwerk AG & Co. KGaA (Germany)
      10. Nihon Kohden Corporation (Japan)
      11. Chart Industries (U.S.)
      12. DeVilbiss Healthcare LLC (U.S.)
      13. Fisher & Paykel Healthcare Limited (New Zealand)
      14. GSK plc (U.K.)
      15. ResMed India (U.S.)
      16. BD (U.S.)
      17. Hamilton Medical (Switzerland)
      18. Abbott (U.S.)
  7. Analyst Views
  8. Future Outlook of the Market